20th Annual NATA Symposium Scientific Programme

Scientific Programme

Thursday, April 4, 2019

MORNING

8:50-9:00 Welcome addresses
Charles-Marc Samama, Paris, France
Rainer Moog, Cottbus, Germany
 

Hall BC

PATIENT BLOOD MANAGEMENT
– PAST, PRESENT AND FUTURE

Charles-Marc Samama, Paris, France
Konrad Messmer, Munich, Germany


9:00-9:20 An anniversary NATA symposium – looking back on 20 years of PBM education
Jean-François Baron, Paris, France

9:20-9:40 PBM: an unproven concept? ‒ the Frankfurt consensus conference
Erhard Seifried, Frankfurt, Germany

9:40-10:00 PBM: the standard of care!
Aryeh Shander, Englewood, NJ, USA

10:00-10:30 Roundtable discussion with speakers and past NATA board members

10:30-11:10 Break and poster visits


Hall BC

PATIENT BLOOD MANAGEMENT IN SURGERY
– PREOPERATIVE PREPARATION

Manuel Muñoz, Málaga, Spain
TBD


11:10-11:25 How to get started and overcome barriers to implementation?
Jean-François Hardy, Montreal, QC, Canada

11:25-11:40 Anaemia and iron deficiency screening and evaluation: a practical approach
Elvira Bisbe, Barcelona, Spain

11:40-11:55 Preoperative iron supplementation – when and how should it be done?
Toby Richards, Perth, WA, Australia

11:55-12:10 Is there a role for EPO in preoperative preparation?
Sigismond Lasocki, Angers, France

12:10-12:40 Discussion


Hall A

PATIENT BLOOD MANAGEMENT
– DOES IT WORK IN CHILDREN TOO?

Jens Meier, Linz, Austria
TBD


11:10-11:30 Perioperative transfusion triggers – all the same as in adults?
Philippe Van der Linden, Brussels, Belgium

11:30-11:50 Factor concentrates in paediatrics – top or flop?
Thorsten Haas, Zurich, Switzerland

11:50-12:10 PBM in paediatric cardiac surgery: NATA guidelines
David Faraoni, Toronto, ON, Canada

12:10-12:40 Discussion



12:40-13:50 Lunchtime industry-sponsored satellite symposia and workshops

13:50-14:30 Break and poster visits


Thursday, April 4, 2019

AFTERNOON

Hall BC

IRON THERAPY IN SPECIAL INDICATIONS

Toby Richards, Perth, WA, Australia
TBD


14:30-14:45 Iron deficiency: causes, global burden and treatment options
TBD

14:45-15:00 Iron therapy in heart failure patients without anaemia – is it useful?
TBD

15:00-15:15 Iron therapy in obstetrics – a global public health challenge
Bernd Froessler, Adelaide, SA, Australia

15:15-15:30 The revival of oral iron: new agents, new dosing regimens
Manuel Muñoz, Málaga, Spain

15:30-16:00 Discussion


Hall A

UNDERRATED MEASURES
IN PATIENT BLOOD MANAGEMENT

Elvira Bisbe, Barcelona, Spain
TBD


14:30-14:45 The role of the surgeon in PBM
Mike Reed, Newcastle upon Tyne, UK

14:45-15:00 Cell salvage – still needed, or too expensive?
Dafydd Thomas, Swansea, Wales, UK

15:00-15:15 Is haemodynamic monitoring a necessary cornerstone of PBM?
Christian von Heymann, Berlin, Germany

15:15-15:30 PBM measures in low-income countries
Tina Tomić Mahečić, Zagreb, Croatia

15:30-16:00 Discussion

16:00-16:40 Break and poster visits


Hall BC

EMERGENCY CARE OF PATIENTS
RECEIVING ANTITHROMBOTICS

Rainer Moog, Cottbus, Germany
TBD


16:40-16:55 Assessing drug-induced bleeding risk and severity
Jerrold H. Levy, Durham, NC, USA

16:55-17:10 Bleeding and emergency procedures in patients on vitamin K antagonists
Beverley J. Hunt, London, UK

17:10-17:25 Bleeding and emergency procedures in patients on direct oral anticoagulants
Charles-Marc Samama, Paris, France

17:25-17:40 Bleeding and emergency procedures in patients on antiplatelet agents
David Faraoni, Toronto, ON, Canada

17:40-18:10 Discussion


Hall A

BEST POSTERS
– PRESENTATIONS AND AWARDS

Jens Meier, Linz, Austria
TBD


16:40-18:10 The presenters of the 8 best-rated abstracts will be invited to give a 5-minute presentation followed by a 3-minute discussion.

The 3 best oral communications will selected by audience voting using the “NATA Forum” App.


Friday, April 5, 2019

MORNING

Hall BC

RED BLOOD CELL TRANSFUSION
– HOW LOW CAN/SHOULD WE GO?

Jean-François Hardy, Montreal, QC, Canada
TBD


9:00-9:20 Is continuous haemoglobin measurement useful?
Azriel Perel, Tel Aviv, Israel

9:20-9:40 Anaemia tolerance during pneumonia, COPD, and weaning
TBD

9:40-10:00 Anaemia tolerance in elderly patients
Jens Meier, Linz, Austria

10:00-10:30 Discussion


Hall A

ANTICOAGULATION

David Faraoni, Toronto, ON, Canada
TBD


9:00-9:20 Coagulopathy of sepsis – time to reconsider anticoagulants?
Jerrold H. Levy, Durham, NC, USA

9:20-9:40 Hospital-acquired thrombosis: a major patient safety issue
Beverley J. Hunt, London, UK

9:40-10:00 VTE prevention: what do the guidelines say?
Charles-Marc Samama, Paris, France

10:00-10:30 Discussion

10:30-11:10 Break and poster visits


Hall BC

STOP THE BLEEDING!

Charles-Marc Samama, Paris, France
Donat R. Spahn, Zurich, Switzerland


11:10-11:25 Fibrinogen or plasma in trauma – which way to go?
Herbert Schöchl, Vienna, Austria

11:25-11:40 NEVER forget tranexamic acid!
Beverley J. Hunt, London, UK

11:40-11:55 Modern coagulation management – possible without POC devices? YES
TBD

11:55-12:10 Modern coagulation management – possible without POC devices? NO
Thorsten Haas, Zurich, Switzerland

12:10-12:40 Discussion


Hall A

SAFETY OF BLOOD AND BLOOD PRODUCTS

José A. García-Erce, Pamplona, Spain
TBD


11:10-11:25 Age of blood: do we have all the answers?
Arturo Pereira Saavedra, Barcelona, Spain

11:25-11:40 Which plasma to use in bleeding?
Rainer Moog, Cottbus, Germany

11:40-11:55 Blood safety issues – what should be tested in 2019?
Peter Schlenke, Graz, Austria

11:55-12:10 Transfusion-associated circulatory overload: increased awareness is needed
Alexander Vlaar, Amsterdam, The Netherlands

12:10-12:40 Discussion



12:40-13:50 Lunchtime industry-sponsored satellite symposia and workshops

13:50-14:30 Break and poster visits


Friday, April 5, 2019

AFTERNOON

Hall BC

BREAKING NEWS

Beverley J. Hunt, London, UK
TBD


14:30-14:50 Treatment of preoperative anaemia in cardiac surgery
Donat R. Spahn, Zurich, Switzerland

14:50-15:10 Hepcidin – the new golden bullet for iron therapy?
Sigismond Lasocki, Angers, France

15:10-15:30 Artificial blood – is there anything new?
TBD

15:30-16:00 Discussion


16:00 Concluding comments
Charles-Marc Samama, Paris, France